ARQT Q1 2023 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$2M71.8% margin

Operating Income

-$76M-2742.4% margin

Net Income

-$80M-2867.2% margin

EPS (Diluted)

$-1.30

QoQ Revenue Growth

-6.1%

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$80M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$379M

Total Liabilities

$240M

Stockholders' Equity

$140M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$2M	-$229,000	+972.5%
Operating Income	-$76M	-$63M	-21.8%
Net Income	-$80M	-$64M	-24.0%